Skip to main navigation Skip to search Skip to main content

The influence of the aziridinyl substituent of benzimidazoles and benzimidazolequinones on toxicity towards normal and Fanconi anaemia cells

  • Karen Fahey
  • , Liz O’Donovan
  • , Miriam Carr
  • , Michael P. Carty
  • , Fawaz Aldabbagh

Research output: Contribution to journalArticlepeer-review

Abstract

Aziridinyl substituted benzimidazolequinones are more toxic than methoxy analogues towards normal human fibroblast cells (GM00637). The aziridinyl substituent is required for hypersensitive killing of Fanconi anaemia (FA) cells (PD20i) deficient in FANCD2. Despite lacking quinone functionality, 4,7-dimethoxy-N-[(aziridin-2-yl)methyl]benzimidazole also induces hypersensitivity from FA cells, similar to their response towards mitomycin C. Expression of FANCD2 (in PD20:RV) corrects FA cell hypersensitivity supporting cellular response via the FANC pathway
Original languageEnglish
Pages (from-to)1873-1879
Number of pages7
JournalEuropean Journal of Medicinal Chemistry
Volume45
Issue number5
Early online date20 Jan 2010
DOIs
Publication statusPublished - May 2010

Keywords

  • Aziridine
  • Bioreductive
  • Cytotoxicity
  • Mitomycin C
  • Quinones

Fingerprint

Dive into the research topics of 'The influence of the aziridinyl substituent of benzimidazoles and benzimidazolequinones on toxicity towards normal and Fanconi anaemia cells'. Together they form a unique fingerprint.

Cite this